Added to YB: 2025-03-17
Pitch date: 2024-12-31
BAX [neutral]
Baxter International Inc.
-34.09%
current return
Author Info
No bio for this author
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$8.9B
Pitch Price
$28.87
Price Target
N/A
Dividend
0.23%
EV/EBITDA
8.16
P/E
-9.07
EV/Sales
1.46
Sector
Health Care Equipment and Supplies
Category
value
Artisan Partners Mid Cap Value Fund Portfolio Holding: Baxter International Inc.
BAX (holding update): Renal care & medical products co. Q4 earnings in-line, but core growth weak. Hurricane disruption impact limited. Restructuring nearly complete, selling non-core ops (BioPharma, kidney biz) at premium. Trades <10x normalized earnings. Growth slowdown likely temporary. High FCF conversion for debt paydown/shareholder returns.
Read full article (1 min)